Cholestatic drugs and bilirubin metabolism.
D000818:Animals; D001646:Bile; D001663:Bilirubin / Q000096:biosynthesis*; D002746:Chlorpromazine / Q000494:pharmacology*; D005965:Glucuronates / Q000378:metabolism; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism*; D008696:Methandrostenolone / Q000494:pharmacology*; D008777:Methyltestosterone / Q000494:pharmacology*; D009639:Norethandrolone / Q000494:pharmacology*; D009641:Norethynodrel / Q000494:pharmacology*; D010640:Phenothiazines / Q000494:pharmacology*; D011346:Prochlorperazine / Q000494:pharmacology*; D011395:Promazine / Q000494:pharmacology*; D051381:Rats; D012636:Secretory Rate; D014273:Triflupromazine / Q000494:pharmacology*
D005965:Glucuronates; D010640:Phenothiazines; D009641:Norethynodrel; D008696:Methandrostenolone; D011395:Promazine; D009639:Norethandrolone; D001663:Bilirubin; D014273:Triflupromazine; D002746:Chlorpromazine; D008777:Methyltestosterone; D011346:Prochlorperazine